Atorvastatin-associated neurological adverse events: a disproportionality analysis with adjustment for confounding by indication - Takeaways - MDSpire

Atorvastatin-associated neurological adverse events: a disproportionality analysis with adjustment for confounding by indication

  • By

  • Xinjun He

  • Qi Zhou

  • Min Zhang

  • Dandan Wang

  • Xinchang Xu

  • July 7, 2026

  • 0 min

Share

  • 1

    A disproportionality analysis of the FAERS database identified 50 neurological adverse event signals associated with atorvastatin.

  • 2

    After excluding confounding reports, 32 significant neurological adverse event signals remained for atorvastatin.

  • 3

    The strongest signals included neuromuscular junction disorders, peripheral neuropathies, and central nervous system disorders.

  • 4

    Exceptional signals without detailed case support included acute necrotising myelitis and vibration syndrome.

  • 5

    This study highlights the need for further validation of atorvastatin's neurological safety profile based on real-world evidence.

Original Source(s)

Atorvastatin-associated neurological adverse events: a disproportionality analysis with adjustment for confounding by indication

  • by Xinjun He, Qi Zhou, Min Zhang, Dandan Wang, Xinchang Xu

  • July 7, 2026

Related Content

Updated Freudian drive theory: childhood trauma, epigenetics, serotonin and beta endorphin

Advances in the multimodal management of central nervous system solitary fibrous tumors

Research progress on addictive features and reward circuit mechanisms in non-suicidal self-injury and the feasibility of precision neuromodulation